Medicinal product name | Atorvastatin TAD 20 mg film-coated tablets |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical form | Film-coated tablet | |||||||||
Strength | 20 mg | |||||||||
Information from the MAH on shortages | No information on expected shortages | |||||||||
Availability of medicinal product |
|
|||||||||
Legal status | Reimbursed medicines reference product |
Prescription (Pr.)|||||||||
Package leaflet | 25-05-2023 | |||||||||
Summary of product characteristics | 25-05-2023 | |||||||||
ATC code | C10AA05 – Lipid modifying agents | |||||||||
Information for Marketing authorisation holders | View |
Medicinal products (14)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N4 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-01 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N7 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-02 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-03 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-04 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-05 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-06 |
Labelling text Oct 8, 2020 |
|
Is available (according to the information provided by wholesalers) (10096 containers) |
Tamro, Magnum Medical, Recipe Plus, Baltfarm "Vita-Farm", Euroaptieka, Jelgavfarm, Oribalt Rīga, Medelens+ |
N30 (20 mg) |
OPA/Al/PVC/Al blister |
€ 1.44 * |
12-0103-07 |
Labelling text Oct 8, 2020 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-08 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-09 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-10 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N84 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-11 |
Labelling text Oct 8, 2020 |
|
Is available (according to the information provided by wholesalers) (5245 containers) |
Tamro, Magnum Medical, Recipe Plus, Euroaptieka, Jelgavfarm, Oribalt Rīga, Medelens+ |
N90 (20 mg) |
OPA/Al/PVC/Al blister |
€ 4.32 * |
12-0103-12 |
Labelling text Oct 8, 2020 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-13 |
Labelling text Oct 8, 2020 |
|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (20 mg) |
OPA/Al/PVC/Al blister | 12-0103-14 |
Labelling text Oct 8, 2020 |
Registration information
Marketing authorisation No. | 12-0103 |
---|---|
Date of authorisation | Apr 16, 2012 |
Marketing authorisation holder, country | TAD Pharma GmbH, Germany |